IRIS
NORIS, PATRIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.023
EU - Europa 2.939
AS - Asia 2.149
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 6
SA - Sud America 4
Totale 9.147
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.993
CN - Cina 2.006
IE - Irlanda 961
UA - Ucraina 471
FI - Finlandia 409
SE - Svezia 291
DE - Germania 267
IT - Italia 263
GB - Regno Unito 123
SG - Singapore 98
FR - Francia 56
CA - Canada 30
IN - India 24
RU - Federazione Russa 23
AU - Australia 16
BE - Belgio 16
RO - Romania 16
CZ - Repubblica Ceca 13
EU - Europa 9
IR - Iran 9
NL - Olanda 8
GR - Grecia 7
MU - Mauritius 5
JP - Giappone 3
AR - Argentina 2
AT - Austria 2
CH - Svizzera 2
DK - Danimarca 2
PT - Portogallo 2
TR - Turchia 2
AL - Albania 1
BD - Bangladesh 1
BR - Brasile 1
CL - Cile 1
ES - Italia 1
ET - Etiopia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
Totale 9.147
Salva come PNG Salva come JPEG
Città #
Dublin 961
Chandler 873
Jacksonville 661
Nanjing 613
Ashburn 288
Boardman 279
Nanchang 224
Princeton 194
Shenyang 183
Wilmington 181
Lawrence 180
Medford 177
Hebei 165
Changsha 164
Beijing 159
Jiaxing 128
Helsinki 99
Tianjin 90
Ann Arbor 89
Hangzhou 88
Milan 67
Singapore 64
Shanghai 53
Woodbridge 47
New York 41
Pavia 40
Houston 39
Verona 32
Fairfield 28
Los Angeles 26
Norwalk 25
Toronto 23
Pune 19
Seattle 18
Guangzhou 17
Brussels 16
Des Moines 14
Jinan 14
Brno 12
Falls Church 12
Timisoara 12
Zhengzhou 12
Auburn Hills 11
Rome 9
Sydney 9
Ningbo 8
Palermo 8
Taizhou 8
Kunming 7
Tappahannock 7
Andover 6
San Francisco 6
Fuzhou 5
Moscow 5
Orange 5
Washington 5
Dearborn 4
Frankfurt am Main 4
Leawood 4
Melbourne 4
Monmouth Junction 4
Munich 4
Padova 4
Redwood City 4
Saint Petersburg 4
Aversa 3
Bari 3
Bologna 3
Borås 3
Brescia 3
Changchun 3
Chicago 3
Chongqing 3
Dallas 3
Falkenstein 3
Florence 3
Laives 3
Lanzhou 3
Sacramento 3
Tokyo 3
Trieste 3
Aprilia 2
Ardabil 2
Caserta 2
Dongguan 2
Fayetteville 2
Genoa 2
Haarlem 2
London 2
Mariglianella 2
Montreal 2
Ottawa 2
Paris 2
Pieve Emanuele 2
Pisa 2
Porto 2
Redmond 2
Rho 2
Rockville 2
Shijiazhuang 2
Totale 6.648
Salva come PNG Salva come JPEG
Nome #
Antigeni minori di istocompatibilità 118
Abdominal lymphographic pattern in connective tissue diseases is quite similar to that observed in lymphocytic lymphoma. 85
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and after surgical repair 82
Spectrum of the mutations in Bernard-Soulier syndrome. 80
Screening for congenital bleeding disorders with platelet function analyzer (PFA-100) in women with menorrhagia 79
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 78
Heparin modifies platelet count and function in patients who have undergone thrombolytic therapy for acute myocardial infarction. 77
IN VIVO AND IN VITRO EFFECTS OF THROMBOLYTIC AGENTS ON PLATELET COMPOSITION AND FUNCTION 77
ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization. 74
Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders 73
A HOMOZYGOUS POINT MUTATION IN A LEUCINE-RICH MOTIF OF PLATELET GLYCOPROTEIN-IX ASSOCIATED WITH BERNARD-SOULIER SYNDROME (BSS) 72
Autoimmunità e piastrinopatie [Autoimmunity and platelet disorders] 71
NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NATP) CAUSED BY A NEW LOW-FREQUENCY PLATELET-SPECIFIC ALLOANTIGEN, MAXA, LOCATED ON GPIIB 71
Effect of low molecular weight heparin on some markers of platelet and thrombin activation in patients with inflammatory bowel diseasesnresponsive to the standard therapy 71
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 70
Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. 70
A new variant of Bernard-Soulier syndrome characterized by dysfunctional glycoprotein (GP) IB and severely reduced amounts of GPIX and GPV. 69
Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly). Clinical and laboratory findings. 69
MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations. 69
Absence of CYCS mutations in a large Italian cohort of patients with inherited thrombocytopenias of unknown origin. 68
NITROGLYCERIN INFUSION - HEMODYNAMIC AND ANTI-PLATELETS EFFECTS IN PATIENTS WITH CARDIOMYOPATHY 68
A Leu40Pro substitution in the leucine rich motif (LRM) of glycoprotein (GP) IX is responsible for dysfunction of a normally expressed GPIB alpha in Bernard-Soulier syndrome (BSS) 68
Inherited thrombocytopenias in the era of personalized medicine 67
Autologous transfusion of thrombosol plus low-dose DMSO cryopreserved platelet concentrates (PCs) for severe thrombocytopenia following high-dose chemotherapy (HDC). 67
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia. 67
Analysis of 65 pregnancies in 34 women with five different forms of inherited platelet function disorders 67
Clinical and pathogenetic characterization of ETV6-related thrombocytopenia (ETV6-RT), an inherited thrombocytopenia (IT) predisposing to childhood acute lymphoblastic leukemia (ALL) 66
Confronto di due metodi di criopreservazione piastrinica basati sull'impiego di glicerolo-glucosio o DMSO: studio della funzionalità piastrinica in vitro. 65
Autologous cryopreserved platelets can efficiently support patients with breast cancer after high-dose chemotherapy and circulating progenitor cell transplantation 65
PLASMA PROTEIN-Z LEVELS AND HEMOSTASIS IN PATIENTS ON DICUMAROL TREATMENT AND IN PATIENTS WITH BLEEDING TENDENCY OF UNKNOWN ORIGIN 64
Platelet function after 'in vivo' and 'in vitro' treatment with thrombolytic agents. 64
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 64
Altered cytoskeleton organization in platelets from patients with MYH9-related disease. 64
Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor. 63
Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. 63
Platelet composition and function in patients undergoing cardiopulmonary bypass for hearth surgery. 63
Effect of 52 monoclonal antibodies against platelet membrane on platelet aggregation and release reaction 63
Splenectomia in corso di porpora trombocitopenica idiopatica: fattori prognostici e risultati clinici. 63
Transfusion of platelet concentrates cryopreserved with thromboSol plus low-dose dimethilsulphoxide in patients with severe thrombocytopenia: a pilot study 62
Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. 62
Factor V Leiden mutation and risk of thrombotic complications in children treated for lynphoprolipherative diseases 62
Application of a Diagnostic Algorithm for Inherited Thrombocytopenia Patients in the Setting of a Developing Country. 62
Platelet count and aging 61
Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on "in vitro" platelet function. 61
Platelet predeposit and transfusion in patients receiving high-dose chemotherapy and autologous transplant for breast cancer 61
Desmopressin and platelets: In vitro and in vivo studies 61
CYCLIC THROMBOCYTOPENIA-THROMBOCYTOSIS WITH A PERIODIC DEFECT OF PLATELET-FUNCTION - REPORT OF A CASE 61
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 61
Platelet-independent defect in hemostasis associated with sirolimus use 61
In vitro and in vivo effects of desmopressin on platelet function 61
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 61
Thrombopoietin levels in patients with primary and reactive thrombocytosis. 60
Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on "in vitro" platelet function 60
Haemophagocytic syndrome responding to high-dose gamma-globulin as presenting feature of sarcoidosis. 60
High prevalence of fibrin formation defects in women with menorrhagia and congenital bleeding disorders 60
Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. 60
Inherited thrombocytopenias. The evolving spectrum. 60
May-Hegglin anomaly: Clinical and laboratory investigation of 14 cases 60
Personalized reference intervals for platelet count reduce the number of subjects with unexplained thrombocytopenia 60
NOVEL PERSPECTIVES IN GENOTYPE-PHENOTYPE CORRELATIONS IN MYH9-RELATED DISEASE: NO LONGER JUST A MATTER OF HEAD OR TAIL 60
Ristocetin-induced platelet agglutination stimulates GPIIb-IIIa-dependent calcium influx. 59
Incompatibility at CD31, HPA3 or HPA5 loci are HLA-A2-restricted risk factors for acute GVHD. 59
Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia 59
Heparin infusion facilitates ex vivo platelet aggregation in patients with acute myocardial infarction who have undergone thrombolytic therapy. 59
Factors influencing post-transfusional platelet increment in pediatric patients given hematopoietic stem cell transplantation. 58
Von Willebrand disease type 2B must be always considered in the differential diagnosis of genetic thrombocytopenias with giant platelets. 58
Defect of platelet aggregation and adhesion induced by autoantibody against glycoprotein IIIa. 58
X-linked thrombocytopenia with thalassemia: Clinical and biological features of a second family 58
A phenylalanine-55 to serine amino-acid substitution in the human glycoprotein IX leucine-rich repeat is associated with Bernard-Soulier syndrome. 57
Peripheral arteriopathy of the lower limbs in a patient with severe congenital thrombocytopenia. 57
The effect of red blood cells on platelet aggregation; a study with the whole blood aggregometer 57
Effetto del Diltiazem sulla funzionalità piastrinica ex vivo 57
Hyperhomocysteinemia and FV ARG 506 GLN in 81 consecutive patients with thrombosis. 57
Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders. 57
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 57
A MONOALLELIC LOSS-FUNCTION MUTATION IN THE THROMBOPOIETIN (THPO) GENE IS RESPONSIBLE FOR A NEW FORM OF INHERITED THROMBOCYTOPENIA (IT) 57
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 57
Incompatibility for CD31 and human platelet antigens and acute graft-versus-host disease after bone marrow transplantation 56
Malattia di von Willebrand tipo IIb: descrizione di un caso clinico 56
ANKRD26-related thrombocytopenia and myeloid malignancies 56
Megakaryocytes derived from patients with the classical form of Bernard-Soulier syndrome show no ability to extend proplatelets in vitro. 55
Is thiazole orange fluorescence of human platelets directly related to their age? 55
Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome) 54
Cys209 Ser mutation in the platelet membrane glycoprotein Ib alpha gene is associated with Bernard-Soulier syndrome 54
ETV6-RELATED THROMBOCYTOPENIA (ETV6-RT): CLINICAL AND PATHOGENETIC CHARACTERIZATION OF AN INHERITED THROMBOCYTOPENIA (IT) PREDISPOSING TO CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) 54
MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. 53
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. 53
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIb{alpha} (Bolzano mutation). 53
Platelet size for distinguishing between inherited thrombocytopenias and immune thrombocytopenia: a multicentric, real life study 52
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 52
Clinical and genetic aspects Bernard-Soulier syndrome: searching for genotype/phenotype correlations. 52
In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: are they laboratory artefacts? 51
Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms 51
NOVEL RUNX1 MUTATIONS IN FAMILIES WITH INHERITED THROMBOCYTOPENIA 51
Heavy chain myosin 9-related disease (MYH9-RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. 50
Safety and efficacy of low dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment. The FONDAIR study. 50
Relationship between size and thiazole orange fluorescence of platelets in patients undergoing high-dose chemotherapy 50
Application of a diagnostic algorithm to 50 consecutive patients with inherited thrombocytopenias 50
A new form of inherited thrombocytopenia due to monoallelic loss of function mutation in the thrombopoietin gene 50
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 50
Totale 6.220
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.456
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020593 0 0 0 84 2 101 27 103 12 182 76 6
2020/20211.012 101 90 34 85 9 123 8 156 80 152 138 36
2021/2022913 24 1 32 17 36 48 14 53 53 35 108 492
2022/20232.615 273 158 15 232 265 271 5 138 1.122 21 67 48
2023/2024890 113 125 33 82 107 240 19 58 11 39 37 26
2024/2025355 48 230 53 24 0 0 0 0 0 0 0 0
Totale 9.543